Wainesten Camargo da Silva is a Ph.D. candidate at Universidade Federal do Tocantins in Palmas, Brazil.
Wainesten Camargo da Silva
Ph.D. candidate
Universidade Federal do Tocantins
From this contributor
Cómo planificar políticas que apoyen la comunidad autista en Brasil: Lecciones de una experiencia en Estados Unidos
Brasil podría aprender de los desafíos y éxitos de otras naciones para convertirse en líder de planificación para las necesidades de personas autistas.
How to plan policies that support the autism community in Brazil: Lessons from a U.S. experience
Brazil could learn from the challenges and successes of other nations to become a leader in planning for the needs of autistic people.
Como planejar políticas que apoiem a comunidade autista no Brasil: lições da experiência dos EUA
O Brasil poderia aprender com os desafios e os sucessos de outros países para se tornar líder no planejamento das necessidades das pessoas autistas.
Explore more from The Transmitter
Measuring plastic in the brain: Improving, but incomplete
Meanwhile, researchers are publishing papers without “sufficient quality control,” says analytical chemist Dušan Materić.
Measuring plastic in the brain: Improving, but incomplete
Meanwhile, researchers are publishing papers without “sufficient quality control,” says analytical chemist Dušan Materić.
Incredible shrinking grant deadlines at the BRAIN Initiative
“A month is crazy,” says one former recipient, referring to a new funding opportunity’s timeline.
Incredible shrinking grant deadlines at the BRAIN Initiative
“A month is crazy,” says one former recipient, referring to a new funding opportunity’s timeline.
Sylvia Fogel, reshaping U.S. autism research strategy
In a wide-ranging and provocative interview, the chair of the federal Interagency Autism Coordinating Committee shares her views on vaccines, regression, neuroimmune conditions and more.
Sylvia Fogel, reshaping U.S. autism research strategy
In a wide-ranging and provocative interview, the chair of the federal Interagency Autism Coordinating Committee shares her views on vaccines, regression, neuroimmune conditions and more.